We Are A Late Stage Biopharmaceutical Company Focused On The Development And Commercialization Of Serlopitant For The Treatment Of Pruritusor Itchassociated With Various Conditionswe Believe That Serlopitanta Highly Selective Small Molecule Inhibitor Of The Neurokinin 1 Receptoror Nk1Rgiven As A Once Dailyoral Tablethas The Potential To Significantly Alleviate Pruritus Associated With Various Conditions
No conferences found for this company.
| Company Name | Menlo Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
